The global artificial cornea and corneal implant market size was valued at USD 468.85 Million in 2024. Looking forward, the analyst estimates the market to reach USD 831.98 Million by 2033, exhibiting a CAGR of 6.25% during 2025-2033. North America currently dominates the market with a market share of 50.5%. The growing prevalence of corneal infections and eye-associated disorders, rising construction of various healthcare facilities, and escalating demand for full-thickness corneal transplantation represent some of the key factors driving the market.
Artificial cornea and corneal implant refer to specific surgical procedures conducted to replace segments of the damaged cornea with healthy and unaffected corneal tissue obtained from a donor. They consist of a wide variety of medical procedures, such as penetrating and endothelial keratoplasty, which involves the transplantation of the entire corneal stem cells. They involve transplantation of implants that are hydrogels in nature and manufactured with recombinant collagen and inserted in a tiny incision made on the cornea of the patient. These procedures are primarily performed for the treatment of infectious keratitis, keratoconus, corneal ulcers, and Fuchs dystrophy diseases.
Artificial cornea and corneal implant are also necessary for curing anterior corneal pathologies, such as trachoma, infectious keratitis, ocular trauma, and chemical injuries. They help improve eyesight, relieve pain, maintain the proper shape of the cornea, and treat severe infections or damage. They also assist in restoring a clear vision of patients suffering from corneal scarring and corneal diseases and enable them to perform daily activities effortlessly.
Apart from this, the increasing demand for full-thickness corneal transplantation due to the rising geriatric population worldwide is contributing to the growth of the market. Additionally, there is a rise in the adoption of minimally invasive (MI) corneal transplantation methods to avoid scarring, fasten the recovery period, and reduce the costs and duration of hospital stays.
This, coupled with the increasing preference for penetrating keratoplasty procedures to treat eye-related complications in older patients, is supporting the market growth. Moreover, the rising utilization of various innovative and effective medical products, such as three-dimensional (3D) printed artificial cornea with better biocompatibility and customizability in treating corneal diseases, is strengthening the market growth.
Some of the companies covered include Advancing Sight Network, AJL Ophthalmic S.A., Aurolab, Corneat Vision Ltd, EyeYon Medical, Florida Lions Eye Bank, Keramed Inc., L V Prasad Eye Institute, LinkoCare Life Sciences AB, Mediphacos, Presbia PLC, San Diego Eye Bank, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Artificial cornea and corneal implant refer to specific surgical procedures conducted to replace segments of the damaged cornea with healthy and unaffected corneal tissue obtained from a donor. They consist of a wide variety of medical procedures, such as penetrating and endothelial keratoplasty, which involves the transplantation of the entire corneal stem cells. They involve transplantation of implants that are hydrogels in nature and manufactured with recombinant collagen and inserted in a tiny incision made on the cornea of the patient. These procedures are primarily performed for the treatment of infectious keratitis, keratoconus, corneal ulcers, and Fuchs dystrophy diseases.
Artificial cornea and corneal implant are also necessary for curing anterior corneal pathologies, such as trachoma, infectious keratitis, ocular trauma, and chemical injuries. They help improve eyesight, relieve pain, maintain the proper shape of the cornea, and treat severe infections or damage. They also assist in restoring a clear vision of patients suffering from corneal scarring and corneal diseases and enable them to perform daily activities effortlessly.
Artificial Cornea and Corneal Implant Market Trends:
At present, the increasing demand for artificial cornea and corneal implants due to the rising prevalence of corneal infections and eye-associated disorders among the masses represents one of the primary factors influencing the market positively. Besides this, the growing construction of various healthcare facilities, such as hospitals, nursing homes, and eye clinics, to provide effective treatment to patients is offering a favorable market outlook. In addition, the rising occurrence of eyesight complications among young individuals for spending prolonged hours looking at smartphones or working on computers and laptops is propelling the growth of the market.Apart from this, the increasing demand for full-thickness corneal transplantation due to the rising geriatric population worldwide is contributing to the growth of the market. Additionally, there is a rise in the adoption of minimally invasive (MI) corneal transplantation methods to avoid scarring, fasten the recovery period, and reduce the costs and duration of hospital stays.
This, coupled with the increasing preference for penetrating keratoplasty procedures to treat eye-related complications in older patients, is supporting the market growth. Moreover, the rising utilization of various innovative and effective medical products, such as three-dimensional (3D) printed artificial cornea with better biocompatibility and customizability in treating corneal diseases, is strengthening the market growth.
Key Market Segmentation:
This report provides an analysis of the key trends in each segment of the global artificial cornea and corneal implant market, along with forecast at the global, regional, and country levels from 2025-2033. The market has been categorized based on type, transplant type, disease indication, and end user.Type Insights:
- Human Cornea
- Artificial Cornea
Transplant Type Insights:
- Penetrating Keratoplasty
- Endothelial Keratoplasty
- Anterior Lamellar Keratoplasty
- Keratoprosthesis
Disease Indication Insights:
- Fuchs' Dystrophy
- Fungal Keratitis
- Keratoconus
- Others
End User Insights:
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
Regional Insights:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global artificial cornea and corneal implant market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.Some of the companies covered include Advancing Sight Network, AJL Ophthalmic S.A., Aurolab, Corneat Vision Ltd, EyeYon Medical, Florida Lions Eye Bank, Keramed Inc., L V Prasad Eye Institute, LinkoCare Life Sciences AB, Mediphacos, Presbia PLC, San Diego Eye Bank, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report:
- What are artificial cornea and corneal implants?
- How big is the artificial cornea and corneal implant market?
- What is the expected growth rate of the global artificial cornea and corneal implant market during 2025-2033?
- What are the key factors driving the global artificial cornea and corneal implant market?
- What is the leading segment of the global artificial cornea and corneal implant market based on the type?
- What is the leading segment of the global artificial cornea and corneal implant market based on the transplant type?
- What is the leading segment of the global artificial cornea and corneal implant market based on the disease indication?
- What is the leading segment of the global artificial cornea and corneal implant market based on the end user?
- What are the key regions in the global artificial cornea and corneal implant market?
- Who are the key players/companies in the global artificial cornea and corneal implant market?
Table of Contents
1 Preface3 Executive Summary12 Value Chain Analysis14 Price Analysis
2 Scope and Methodology
4 Introduction
5 Global Artificial Cornea and Corneal Implant Market
6 Market Breakup by Type
7 Market Breakup by Transplant Type
8 Market Breakup by Disease Indication
9 Market Breakup by End User
10 Market Breakup by Region
11 SWOT Analysis
13 Porters Five Forces Analysis
15 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- Advancing Sight Network
- AJL Ophthalmic S.A.
- Aurolab
- Corneat Vision Ltd
- EyeYon Medical
- Florida Lions Eye Bank
- Keramed Inc.
- L V Prasad Eye Institute
- LinkoCare Life Sciences AB
- Mediphacos
- Presbia PLC
- San Diego Eye Bank
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 136 |
| Published | April 2025 |
| Forecast Period | 2024 - 2033 |
| Estimated Market Value ( USD | $ 468.85 Million |
| Forecasted Market Value ( USD | $ 831.98 Million |
| Compound Annual Growth Rate | 6.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 12 |
